Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8+ memory T cells

European Journal of Immunology

Volumn 43, Issue 3, 2013, Pages 693-704

  Tartz, Susanne ^a   Deschermeier, Christina ^a   Retzlaff, Silke ^a   Heussler, Volker ^b   Sebo, Peter ^c   Fleischer, Bernhard ^a,d   Jacobs, Thomas ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CD8+ T cells; Plasmodium; Sporozoites; Vaccination

Indexed keywords

NEUTRALIZING ANTIBODY; PLASMODIUM CIRCUMSPOROZOITE PROTEIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SPOROZOITE; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, HUMORAL; IMMUNIZATION; IMMUNOLOGIC MEMORY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PHENOTYPE; PLASMODIUM BERGHEI; SPOROZOITES;

EID: 84874981786     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142262     Document Type: Article

References (47)

1. WHO, World Malaria Report 2010, WHO Press, Geneva, Switzerland, 2010.
2. Doolan, D. L., Dobano, C. and Baird, J. K., Acquired immunity to malaria. Clin. Microbiol. Rev. 2009. 22: 13-36.
3. Gupta, S., Snow, R. W., Donnelly, C. A., Marsh, K. and Newbold, C., Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 1999. 5: 340-343.
4. Hudson Keenihan, S. N., Ratiwayanto, S., Soebianto, S., Krisin, Marwoto, H., Krishnegowda, G., Gowda, D. C. et al., Age-dependent impairment of IgG responses to glycosylphosphatidylinositol with equal exposure to Plasmodium falciparum among Javanese migrants to Papua, Indonesia. Am. J. Trop. Med. Hyg. 2003. 69: 36-41.
5. Ofori, M. F., Dodoo, D., Staalsoe, T., Kurtzhals, J. A., Koram, K., Theander, T. G., Akanmori, B. D. and Hviid, L., Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect Immun. 2002. 70: 2982-2988.
6. Nielsen, M. A., Staalsoe, T., Kurtzhals, J. A., Goka, B. Q., Dodoo, D., Alifrangis, M., Theander, T. G. et al., Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity. J. Immunol. 2002. 168: 3444-3450.
7. Struik, S. S. and Riley, E. M., Does malaria suffer from lack of memory? Immunol. Rev. 2004. 201: 268-290.
8. Jennings, R. M., JB, D. E. S., Todd, J. E., Armstrong, M., Flanagan, K. L., Riley, E. M. and Doherty, J. F., Imported Plasmodium falciparum malaria: are patients originating from disease-endemic areas less likely to develop severe disease? A prospective, observational study. Am. J. Trop. Med. Hyg. 2006. 75: 1195-1199.
9. Jelinek, T., Schulte, C., Behrens, R., Grobusch, M. P., Coulaud, J. P., Bisoffi, Z., Matteelli, A. et al., Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin. Infect. Dis. 2002. 34: 572-576.
10. Nussenzweig, R. S., Vanderberg, J., Most, H. and Orton, C., Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967. 216: 160-162.
11. Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. and Good, M. F., CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 1988. 85: 573-576.
12. Clyde, D. F., Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 1975. 24: 397-401.
13. Mueller, A. K., Labaied, M., Kappe, S. H. and Matuschewski, K., Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005. 433: 164-167.
14. Zavala, F., Cochrane, A. H., Nardin, E. H., Nussenzweig, R. S. and Nussenzweig, V., Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J. Exp. Med. 1983. 157: 1947-1957.
15. Kumar, S., Miller, L. H., Quakyi, I. A., Keister, D. B., Houghten, R. A., Maloy, W. L., Moss, B. et al., Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 1988. 334: 258-260.
16. Hoffman, S. L., Isenbarger, D., Long, G. W., Sedegah, M., Szarfman, A., Mellouk, S. and Ballou, W. R., T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes. Bull. World Health Organ. 1990. 68 Suppl: 132-137.
17. Weiss, W. R., Mellouk, S., Houghten, R. A., Sedegah, M., Kumar, S., Good, M. F., Berzofsky, J. A. et al., Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 1990. 171: 763-773.
18. Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R. and Nussenzweig, V., Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987. 330: 664-666.
19. Allsopp, C. E., Plebanski, M., Gilbert, S., Sinden, R. E., Harris, S., Frankel, G., Dougan, G. et al., Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 1996. 26: 1951-1959.
20. Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M. et al., Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 1998. 4: 397-402.
21. Gilbert, S. C., Schneider, J., Hannan, C. M., Hu, J. T., Plebanski, M., Sinden, R. and Hill, A. V., Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 2002. 20: 1039-1045.
22. Anderson, R. J., Hannan, C. M., Gilbert, S. C., Laidlaw, S. M., Sheu, E. G., Korten, S., Sinden, R. et al., Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J. Immunol. 2004. 172: 3094-3100.
23. Tartz, S., Russmann, H., Kamanova, J., Sebo, P., Sturm, A., Heussler, V., Fleischer, B. and Jacobs, T., Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid. Vaccine 2008. 26: 5935-5943.
24. Schlecht, G., Loucka, J., Najar, H., Sebo, P. and Leclerc, C., Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J. Immunol. 2004. 173: 6089-6097.
25. Preville, X., Ladant, D., Timmerman, B. and Leclerc, C., Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res. 2005. 65: 641-649.
26. Osicka, R., Osickova, A., Basar, T., Guermonprez, P., Rojas, M., Leclerc, C. and Sebo, P., Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect Immun. 2000. 68: 247-256.
27. Mackova, J., Stasikova, J., Kutinova, L., Masin, J., Hainz, P., Simsova, M., Gabriel, P. et al., Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara. Cancer Immunol. Immunother. 2006. 55: 39-46.
28. Tartz, S., Kamanova, J., Simsova, M., Sebo, P., Bolte, S., Heussler, V., Fleischer, B. and Jacobs, T., Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria. Infect Immun. 2006. 74: 2277-2285.
29. Mueller, A. K., Deckert, M., Heiss, K., Goetz, K., Matuschewski, K. and Schluter, D., Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am. J. Pathol. 2007. 171: 107-115.
30. Schmidt, N. W., Butler, N. S. and Harty, J. T., CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge. Vaccine 2009. 27: 6103-6106.
31. Voehringer, D., Blaser, C., Brawand, P., Raulet, D. H., Hanke, T. and Pircher, H., Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 2001. 167: 4838-4843.
32. Hikono, H., Kohlmeier, J. E., Takamura, S., Wittmer, S. T., Roberts, A. D. and Woodland, D. L., Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 2007. 204: 1625-1636.
33. Prlic, M., Sacks, J. A. and Bevan, M. J., Dissociating markers of senescence and protective ability in memory T cells. PLoS One 2012. 7: e32576.
34. Messer, R. J., Dittmer, U., Peterson, K. E. and Hasenkrug, K. J., Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. Proc. Natl. Acad. Sci. USA 2004. 101: 12260-12265.
35. Michaud, H. A., Gomard, T., Gros, L., Thiolon, K., Nasser, R., Jacquet, C., Hernandez, J. et al., A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy. PLoS Pathog. 2010. 6: e1000948.
36. Bachmann, M. F., Hunziker, L., Zinkernagel, R. M., Storni, T. and Kopf, M., Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key. Eur. J. Immunol. 2004. 34: 317-326.
37. Nardin, E. H., Nussenzweig, R. S., McGregor, I. A. and Bryan, J. H., Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science 1979. 206: 597-599.
38. Miller, K. D., Campbell, G. H., Nutman, T. B., Mulligan, M., Currie, B., Procell, P. M. and Roberts, J. M., Early acquisition of antibody to Plasmodium falciparum sporozoites in nonimmune temporary residents of Africa. J. Infect Dis. 1988. 158: 868-871.
39. Ocana-Morgner, C., Mota, M. M. and Rodriguez, A., Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 2003. 197: 143-151.
40. Ocana-Morgner, C., Wong, K. A. and Rodriguez, A., Interactions between dendritic cells and CD4+ T cells during Plasmodium infection. Malar. J. 2008. 7: 88.
41. Urban, B. C., Ferguson, D. J., Pain, A., Willcox, N., Plebanski, M., Austyn, J. M. and Roberts, D. J., Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999. 400: 73-77.
42. Hirunpetcharat, C. and Good, M. F., Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite. Proc. Natl. Acad. Sci. USA 1998. 95: 1715-1720.
43. Wipasa, J., Xu, H., Stowers, A. and Good, M. F., Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection. J. Immunol. 2001. 167: 3903-3909.
44. Kaniga, K., Uralil, J., Bliska, J. B. and Galan, J. E., A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 1996. 21: 633-641.
45. Hoiseth, S. K. and Stocker, B. A., Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981. 291: 238-239.
46. Russmann, H., Shams, H., Poblete, F., Fu, Y., Galan, J. E. and Donis, R. O., Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998. 281: 565-568.
47. Kursar, M., Kohler, A., Kaufmann, S. H. and Mittrucker, H. W., Depletion of CD4+ T cells during immunization with nonviable Listeria monocytogenes causes enhanced CD8+ T cell-mediated protection against listeriosis. J. Immunol. 2004. 172: 3167-3172.